1. Home
  2. CMU vs APLT Comparison

CMU vs APLT Comparison

Compare CMU & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMU
  • APLT
  • Stock Information
  • Founded
  • CMU 1987
  • APLT 2016
  • Country
  • CMU United States
  • APLT United States
  • Employees
  • CMU N/A
  • APLT N/A
  • Industry
  • CMU Investment Managers
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMU Finance
  • APLT Health Care
  • Exchange
  • CMU Nasdaq
  • APLT Nasdaq
  • Market Cap
  • CMU 89.6M
  • APLT 80.3M
  • IPO Year
  • CMU N/A
  • APLT 2019
  • Fundamental
  • Price
  • CMU $3.56
  • APLT $0.65
  • Analyst Decision
  • CMU
  • APLT Buy
  • Analyst Count
  • CMU 0
  • APLT 7
  • Target Price
  • CMU N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • CMU 82.4K
  • APLT 3.5M
  • Earning Date
  • CMU 01-01-0001
  • APLT 03-05-2025
  • Dividend Yield
  • CMU 4.08%
  • APLT N/A
  • EPS Growth
  • CMU N/A
  • APLT N/A
  • EPS
  • CMU 0.07
  • APLT N/A
  • Revenue
  • CMU N/A
  • APLT N/A
  • Revenue This Year
  • CMU N/A
  • APLT N/A
  • Revenue Next Year
  • CMU N/A
  • APLT $2,622.90
  • P/E Ratio
  • CMU $47.57
  • APLT N/A
  • Revenue Growth
  • CMU N/A
  • APLT N/A
  • 52 Week Low
  • CMU $2.78
  • APLT $0.54
  • 52 Week High
  • CMU $3.38
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • CMU 56.76
  • APLT 35.67
  • Support Level
  • CMU $3.52
  • APLT $0.54
  • Resistance Level
  • CMU $3.58
  • APLT $0.66
  • Average True Range (ATR)
  • CMU 0.03
  • APLT 0.06
  • MACD
  • CMU 0.00
  • APLT 0.09
  • Stochastic Oscillator
  • CMU 73.75
  • APLT 81.26

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: